Exercise News and Research

Latest Exercise News and Research

Link between physical fitness and iron or vitamin status in adolescents

Adolescence is an important time not only for growing but for acquiring healthy habits that will last a lifetime, such as choosing foods rich in vitamins and minerals, and adopting a regular exercise regimen. Unfortunately, several studies have shown that adolescents' intake of important nutrients, as well as their performance on standard physical fitness tests, has fallen in recent years.

9 Aug 2012

Active video games can play a role in getting some people more active

Active video games, also known as "exergames," are not the perfect solution to the nation's sedentary ways, but they can play a role in getting some people to be more active.

9 Aug 2012

Mindfulness yoga may offer effective treatment for depressed new mothers

It's no secret that pregnancy hormones can dampen moods, but for some expectant moms, it's much worse: 1 in 5 experience major depression. Now, new research shows that an age-old recommended stress-buster may actually work for this group of women: yoga.

9 Aug 2012

Jared Foundation, MGM Resorts partner to fight childhood obesity

MGM Resorts International and the Jared Foundation announced plans to work toward expanding a program that addresses chronic weight and obesity issues among children living in the region.

9 Aug 2012

Lightlake announces final data from naloxone nasal spray Phase II study on Binge Eating Disorder

Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing modern addiction treatments based on its expertise using opioid antagonists, announced today compelling final data from a Phase II study of the Company's proprietary opioid antagonist naloxone nasal spray treatment for patients with Binge Eating Disorder (BED).

9 Aug 2012

Bristol-Myers Squibb completes tender offer for all outstanding shares of Amylin

Bristol-Myers Squibb Company announced today the successful completion of the tender offer by Bristol-Myers Squibb Company through its wholly owned subsidiary, B&R Acquisition Company, for all of the outstanding shares of common stock of Amylin Pharmaceuticals, Inc. at a purchase price of $31.00 per share.

8 Aug 2012

Preventing falls in older people through balance and strength training

Balance and strength training that is integrated into everyday activities can reduce the number of falls among older people by almost a third, finds a study published on bmj.com today.

8 Aug 2012

Healthcare professionals receive SingHealth Duke-NUS Scientific Congress abstract awards

Results of the highly anticipated Best Oral Presentation and Best Poster Awards were announced at SingHealth Duke-NUS Scientific Congress 2012, held on 3 and 4 August 2012 at the Raffles City Convention Centre.

8 Aug 2012

Dieters experience drops in basal metabolic rate, in spite of daily exercise

The International Association for the Study of Obesity has bad news for dieters: as reported in the New York Times, the commonly held belief that exercise is a magic metabolism booster may be largely unfounded. A new study finds that people who lost weight experienced drops in basal metabolic rate (BMR), in spite of daily exercise.

8 Aug 2012

USPTO issues patent to Aeterna Zentaris’ AEZS-130 oral test for AGHD

Aeterna Zentaris Inc. today announced that the United States Patent and Trademark Office has granted a patent for the use of its oral ghrelin agonist, AEZS-130 (EP1572) as a diagnostic test for adult growth hormone deficiency.

7 Aug 2012

Orexigen Therapeutics reports net loss of $16.7 million for second quarter 2012

Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2012.

7 Aug 2012

Mylan receives final FDA approval for Montelukast Sodium Tablets ANDA

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Montelukast Sodium Tablets, 10 mg, the generic version of Merck's Singulair Tablets.

7 Aug 2012

Scientists discover biological marker that may help identify patients’ response to antidepressants

Scientists have discovered a biological marker that may help to identify which depressed patients will respond to an experimental, rapid-acting antidepressant. The brain signal, detectable by noninvasive imaging, also holds clues to the agent's underlying mechanism, which are vital for drug development, say National Institutes of Health researchers.

7 Aug 2012

Researchers identify myostatin as potential therapeutic target for muscular disorders

The study of muscular system protein myostatin has been of great interest to researchers as a potential therapeutic target for people with muscular disorders. Although much is known about how myostatin affects muscle growth, there has been disagreement about what types of muscle cells it acts upon. New research from a team including Carnegie's Chen-Ming Fan and Christoph Lepper narrows down the field to one likely type of cell.

7 Aug 2012